Alterity Therapeutics Limited
ATHE
$5.07
-$0.09-1.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.11% | 33.24% | 2.75% | 42.19% | -0.21% |
| Total Depreciation and Amortization | 1.90% | -10.97% | -2.47% | 0.00% | 0.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.13% | -46.16% | -2.74% | 150.75% | 0.20% |
| Change in Net Operating Assets | 2.12% | 166.87% | 2.75% | -149.50% | 0.21% |
| Cash from Operations | -2.11% | 64.40% | 2.75% | -4.79% | -0.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.12% | -- | -- | -- | -- |
| Cash from Investing | -2.12% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 13.78% | 0.00% | -253.60% | 0.00% |
| Issuance of Common Stock | 0.00% | 10,480.03% | 0.00% | -95.46% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -8,468.75% | 0.00% | 95.11% | 0.00% |
| Cash from Financing | 2.12% | 12,604.63% | -2.70% | -96.29% | 0.20% |
| Foreign Exchange rate Adjustments | -2.02% | -268.66% | 2.19% | -115.78% | 0.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.12% | 440.07% | 2.74% | -2,687.61% | 0.19% |